Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population

• Published in: Medical oncology (Northwood, London, England) London, England), 2014-08, Vol.31 (8), p.111-111, Article 111
• Main Authors: Hashemi, Mohammad, Amininia, Sahadi, Ebrahimi, Mahboubeh, Hashemi, Seyed Mehdi, Yousefi, Javad, Eskandari-Nasab, Ebrahim, Taheri, Mohsen, Ghavami, Saeid
• Format: Article
• Language: English
• Subjects: Base Sequence; Breast cancer; Breast Neoplasms - genetics; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Hematology; Humans; Internal Medicine; Iran; Medicine; Medicine & Public Health; Membrane Proteins - genetics; Middle Aged; Molecular Sequence Data; Odds Ratio; Oncogene Proteins - genetics; Oncology; Original Paper; Pathology
• ISSN: 1357-0560; 1559-131X
• DOI: 10.1007/s12032-014-0111-8

Lysosome associated protein transmembrane 4beta (LAPTM4B) contribute to the risk of numerous cancers. The present study focused on the possible association between LAPTM4B polymorphism and the risk of breast cancer (BC) in an Iranian population in southeast Iran. This case control study includes 311 BC patients and 225 healthy women. Genomic DNA was extracted from the whole blood by salting out method and LAPTM4B genotype was investigated using polymerase chain reaction. Our findings showed that LAPTM4B genotype was not associated with the risk of BC in any inheritance model tested. The minor allele frequency in case and control group was 0.297 and 0.278, respectively. The minor allele (LAPTM4B*2) was not associated with BC risk in comparison with LAPTM4B*1 allele (odds ratio 1.10, 95 % confidence intervals 0.84–1.44, p  = 0.495). Moreover, LAPTM4B polymorphism was not associated with clinical and pathological characteristics in the patient group. In conclusion, the findings of our study suggested that the polymorphism of LAPTM4B gene was not associated with susceptibility to BC and clinicopathological characteristics in an Iranian population.